These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 10343012)
21. Pharmaceutical industry wins "round one" in protections against product liability claims. Gatty B Hosp Formul; 1995 Apr; 30(4):238, 237. PubMed ID: 10141868 [No Abstract] [Full Text] [Related]
22. The development of implants and implantable materials. DeMane CQ Otolaryngol Clin North Am; 1995 Apr; 28(2):225-34. PubMed ID: 7596603 [TBL] [Abstract][Full Text] [Related]
23. Civil and criminal liability associated with food recalls. Packman JM Food Drug Law J; 1998; 53(3):437-52. PubMed ID: 10346721 [No Abstract] [Full Text] [Related]
24. Epidemiology as more than statistics: a revised tool for products liability. Berlin RJ Tort Trial Insur Pract Law J; 2006; 42(1):81-103. PubMed ID: 17486721 [No Abstract] [Full Text] [Related]
26. Silicone breast implants. Can emerging medical, legal, and scientific concepts be reconciled? Snyder JW J Leg Med; 1997 Jun; 18(2):133-220. PubMed ID: 9230567 [No Abstract] [Full Text] [Related]
27. Consumer-directed advertising of contraceptive drugs: the FDA, Depo-Provera, and product liability. Green W Food Drug Law J; 1995; 50(4):553-67. PubMed ID: 10343019 [No Abstract] [Full Text] [Related]
28. The Lohr decision: FDA perspective and position. Porter MJ Food Drug Law J; 1997; 52(1):7-11. PubMed ID: 10346705 [No Abstract] [Full Text] [Related]
29. Premarket approval and federal preemption of product liability claims in the wake of Medtronic, Inc. v. Lohr. Jarcho DG Food Drug Law J; 1996; 51(4):613-8. PubMed ID: 11797730 [No Abstract] [Full Text] [Related]
30. Cough up that cash. Farley CJ Time; 1995 Mar; 145(9):47. PubMed ID: 10140721 [No Abstract] [Full Text] [Related]
31. Legal overprotection. Friedman JH Med Health R I; 2004 Oct; 87(10):294. PubMed ID: 15559378 [No Abstract] [Full Text] [Related]
33. Medical device preemption after Medtronic, Inc. v. Lohr. Neraas MB Food Drug Law J; 1996; 51(4):619-29. PubMed ID: 11797731 [No Abstract] [Full Text] [Related]
34. An experiment in Tort reform. Flamberg G Public Health Rep; 1995; 110(5):635-8. PubMed ID: 7480621 [No Abstract] [Full Text] [Related]
35. Greater and lesser powers of tort reform: the primary jurisdiction doctrine and state-law claims concerning FDA-approved products. Struve CT Cornell Law Rev; 2008 Jul; 93(5):1039-74. PubMed ID: 18618970 [No Abstract] [Full Text] [Related]
36. Implantable medical devices and products liability. Posner K Med Trial Tech Q; 1982; 28(3):255-78. PubMed ID: 6927801 [No Abstract] [Full Text] [Related]
37. Torts and innovation. Parchomovsky G; Stein A Mich Law Rev; 2008 Nov; 107(2):285-316. PubMed ID: 19031655 [TBL] [Abstract][Full Text] [Related]
38. Product liability implications of biomaterials in the United States. Price JM Clin Mater; 1994; 16(4):223-7. PubMed ID: 10184317 [No Abstract] [Full Text] [Related]
39. Manufacturers' liability for drugs and medical devices under the Restatement (Third) of Torts: Products Liability. Dreier WA Seton Hall Law Rev; 1999; 30(1):258-64. PubMed ID: 10848105 [TBL] [Abstract][Full Text] [Related]
40. Biomaterials science at a crossroads: are current product liability laws in the United States hampering innovation and the development of safer medical implants? Kohn J Pharm Res; 1996 Jun; 13(6):815-9. PubMed ID: 8792416 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]